Myriad Genetics (MYGN) Acquisitions (2011 - 2018)

Myriad Genetics (MYGN) has reported Acquisitions for 4 consecutive years, with -$1.1 million the latest figure, recorded in Q4 2018.

• In Q4 2018, Acquisitions changed N/A year-over-year to -$1.1 million; the TTM figure through Dec 2020 stood at -$1.1 million (changed N/A YoY), while the FY2022 annual figure was $57.2 million, changed N/A from the prior year.
• Acquisitions retreated to -$1.1 million in Q4 2018 per MYGN's latest filing, from $279.6 million in the prior quarter.
• Across five years, Acquisitions topped out at $279.6 million in Q3 2018 and bottomed at -$1.1 million in Q4 2018.
• Historically, Acquisitions has averaged $98.9 million across 3 years, with a median of $3.1 million in 2016.